Anticoagulants
A brief digest about this topic
If you have some kinds of heart or blood vessel disease, or if you have poor blood flow to your brain, your doctor may recommend that you take a blood thinner. Blood thinners reduce the risk of heart attack and stroke by reducing the formation of blood clots in your arteries and veins. You may also take a blood thinner if you have
- An abnormal heart rhythm called atrial fibrillation
- Heart valve surgery
- Congenital heart defects
There are two main types of blood thinners. Anticoagulants, such as heparin or warfarin (also called Coumadin), work on chemical reactions in your body to lengthen the time it takes to form a blood clot. Antiplatelet drugs, such as aspirin, prevent blood cells called platelets from clumping together to form a clot.
When you take a blood thinner, follow directions carefully. Make sure that your healthcare provider knows all of the medicines and supplements you are using.
Provided by: NIH - National Institute of Health
Links shared publicly online about this topic
Anticoagulation postablation
theheart.org — “Despite the positive findings, an editorial calls the study hypothesis-generating, noting that the AF field needs a prospective randomized clinical trial, one that includes standardized methods to assess and characterize recurrence of AF and to determine the incidence/prevalence of stroke.” View full resource at theheart.org
Most Recently Shared on February 19, 2010 at 4:32 pm By:
Warfarin can be stopped at three to six months postablation of AF, but editorial urges caution: Despite the positi... http://bit.ly/azRe7A
Lupus anticoagulants Information on Healthline
healthline.com — “Lupus anticoagulants are antibodies against phospholipids (substances in the lining of cells) that prevent blood clotting in a test tube. Persons with these antibodies may have an abnormally high risk of blood clotting.” View full resource at healthline.com
Most Recently Shared on December 5, 2010 at 10:25 am By:
#lupus Lupus anticoagulants are antibodies against phospholipids and are used to reduce blood clotting. Learn more. http://sns.ly/xgM74
Family Medicine Article | Anticoagulants
mdlinx.com — “Novel Oral Anticoagulants in Development: Dabigatran, Rivaroxaban, and Apixaban” View full resource at mdlinx.com
Most Recently Shared on July 14, 2011 at 7:39 pm By:
Novel Oral Anticoagulants in Development: Dabigatran, Rivaroxaban, and Apixaban: American Journal o... http://bit.ly/nrPHlw #FamPractice
Drug Challenge: Anticoagulants
nursingcenter.com — “- Do you know what they contain? Match the brand names in Section I with the generic ingredients in Section II._____ 1. Arixtra (GlaxoSmithKline)_____ 2. Coumadin (Bristol-Myers Squibb)_____ 3. L” View full resource at nursingcenter.com
Most Recently Shared on February 18, 2011 at 11:58 am By:
New era for anticoagulant therapy
news-medical.net — “In a Guest Editorial published in the new publication Clinical Investigation, Dr Jeffrey Weitz and Dr John Eikelboom of McMaster University in Hamilton, Canada highlight the importance of the approval in October by the FDA of dabigatran etexilate (Pradaxa®; Boehringer Ingelheim). This new oral thrombin inhibitor provides an alternative to warfarin for long-term stroke prevention in patients with non-valvular atrial fibrillation.” View full resource at news-medical.net
Most Recently Shared on December 23, 2010 at 12:45 am By:
Stroke News: New era for anticoagulant therapy: In a Guest Editorial published in the new publication Clinical... http://twurl.nl/iei23e
New oral anticoagulants for AF
drjohnm.org — “It’s been awhile since I have written about the treatment of atrial fibrillation (AF). I would like to remedy this by sharing a few thoughts on three recent stories about AF: one involved a soon-to-be-approved blood-thinning drug; the second highlighted” View full resource at drjohnm.org
Most Recently Shared on June 26, 2011 at 1:36 pm By:
Some thoughts on recent AF (#afib) news... Part 1- New blood thinners http://ow.ly/5qx3r
Anticoagulation update - - Drug Topics
drugtopics.modernmedicine.com — “The latest info on VTE in HIV; intracerebral hemorrhage; and antiplatelet/warfarin combinations” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on February 11, 2011 at 7:46 pm By:
Anticoagulation update: The latest info on VTE in HIV; intracerebral hemorrhage; and antiplatelet/warfarin com... http://bit.ly/glLp9k
Cardiology Medical News about Anticoagulants
mdlinx.com — “New options with dabigatran etexilate in anticoagulant therapy” View full resource at mdlinx.com
Most Recently Shared on May 18, 2010 at 5:21 pm By:
New options with dabigatran etexilate in anticoagulant therapy: Vascular Health and Risk Management http://bit.ly/9Zdy1S #cardio #mdlinx
Pharmacologic Anticoagulation Reversal in the Emergency Department
nursingcenter.com — “-To provide the registered professional nurse with an overview of the management issues associated with anticoagulant reversal in the emergency department.” View full resource at nursingcenter.com
Most Recently Shared on September 9, 2011 at 1:51 am By:
Pharmacologic Anticoagulation Reversal in the Emergency Department http://t.co/mTi87dM [Advanced Emergency Nursing Journal]
Measuring Quality Of Care In Oral Anticoagulation
medicalnewstoday.com — “Researchers from Boston University School of Medicine (BUSM) and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range (TTR) should be used as part of an effor” View full resource at medicalnewstoday.com
Most Recently Shared on January 4, 2011 at 5:05 pm By:
Measuring Quality Of Care In Oral Anticoagulation http://mnt.to/3PBG #stroke
Pediatrics Medical News about Anticoagulation
mdlinx.com — “Aspects of anticoagulation in children” View full resource at mdlinx.com
Most Recently Shared on June 15, 2010 at 2:30 pm By:
Aspects of anticoagulation in children: British Journal of Haematology http://bit.ly/crRrzb #peds
Oncology Medical News about Anticoagulation
mdlinx.com — “Aspects of anticoagulation in children” View full resource at mdlinx.com
Most Recently Shared on June 16, 2010 at 11:27 pm By:
Aspects of anticoagulation in children: British Journal of Haematology http://bit.ly/bUlJ3n #oncology
Generic Lovenox approved for anticoagulation - ONA
oncologynurseadvisor.com — “The FDA has granted Sandoz approval of a generic version of Lovenox (enoxaparin sodium injection, from sanofi aventis).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 26, 2010 at 5:09 pm By:
Generic Lovenox approved for anticoagulation http://goo.gl/fb/zywjg
Generic Lovenox approved for anticoagulation - MPR
empr.com — “The FDA has granted Sandoz approval of a generic version of Lovenox (enoxaparin sodium injection, from sanofi aventis).” View full resource at empr.com
Most Recently Shared on July 26, 2010 at 5:10 pm By:
MPR News: Generic Lovenox approved for anticoagulation: The FDA has granted Sandoz approval of a generic version o... http://bit.ly/c3cox7
Stroke Anticoagulation and Prophylaxis: eMedicine Neurology
emedicine.medscape.com — “Overview: Anticoagulation is the controlled therapeutic inhibition of blood coagulation by means of appropriate drugs (ie, anticoagulants). The role of anticoagulants in the treatment of cerebral ischemia has changed. For many years, anticoagulation was used routinely in ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 31, 2010 at 7:53 pm By:
Stroke Anticoagulation and Prophylaxis updated: http://bit.ly/bM067T.
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Health Line
Healthline provides free, doctor-reviewed health information on Lupus Erythematosus and a variety of other diseases and conditions.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

